Transforming growth factor β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells

Jian Gen Gong, Sudhakar Ammanamanchi, Tien C. Ko, Michael G. Brattain

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

We examined transforming growth factor-β1 (TGF-β1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-β1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-β1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-β1 inhibition of CDK2 kinase activity. Although TGF-β1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-β1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-β1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-β1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.

Original languageEnglish (US)
Pages (from-to)3340-3346
Number of pages7
JournalCancer Research
Volume63
Issue number12
StatePublished - Jun 15 2003

Fingerprint

Cyclin-Dependent Kinase 2
Transforming Growth Factors
Human Activities
Colon
Phosphotransferases
Carcinoma
Cyclin A
Cyclin E
Cyclins
Cyclin-Dependent Kinases
S Phase
Cell Cycle
Proteins
Cyclin-Dependent Kinase Inhibitor p21
Protein Stability
DNA
G1 Phase
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Transforming growth factor β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. / Gong, Jian Gen; Ammanamanchi, Sudhakar; Ko, Tien C.; Brattain, Michael G.

In: Cancer Research, Vol. 63, No. 12, 15.06.2003, p. 3340-3346.

Research output: Contribution to journalArticle

Gong, Jian Gen ; Ammanamanchi, Sudhakar ; Ko, Tien C. ; Brattain, Michael G. / Transforming growth factor β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. In: Cancer Research. 2003 ; Vol. 63, No. 12. pp. 3340-3346.
@article{a1cde5ea0ee046ba8fcc9fc08bbb0af2,
title = "Transforming growth factor β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells",
abstract = "We examined transforming growth factor-β1 (TGF-β1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-β1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-β1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-β1 inhibition of CDK2 kinase activity. Although TGF-β1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-β1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-β1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-β1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.",
author = "Gong, {Jian Gen} and Sudhakar Ammanamanchi and Ko, {Tien C.} and Brattain, {Michael G.}",
year = "2003",
month = "6",
day = "15",
language = "English (US)",
volume = "63",
pages = "3340--3346",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Transforming growth factor β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells

AU - Gong, Jian Gen

AU - Ammanamanchi, Sudhakar

AU - Ko, Tien C.

AU - Brattain, Michael G.

PY - 2003/6/15

Y1 - 2003/6/15

N2 - We examined transforming growth factor-β1 (TGF-β1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-β1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-β1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-β1 inhibition of CDK2 kinase activity. Although TGF-β1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-β1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-β1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-β1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.

AB - We examined transforming growth factor-β1 (TGF-β1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-β1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-β1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-β1 inhibition of CDK2 kinase activity. Although TGF-β1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-β1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-β1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-β1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.

UR - http://www.scopus.com/inward/record.url?scp=0038407335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038407335&partnerID=8YFLogxK

M3 - Article

C2 - 12810668

AN - SCOPUS:0038407335

VL - 63

SP - 3340

EP - 3346

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -